Illinois will treat consumable and topical hemp products with more than 0.4 mg of total THC per container as cannabis starting November 12, 2026, according to an Illinois Department of Revenue bulletin published October 14. That is a month before the federal 0.4 mg line takes hold on December 11, and the state date is the one that binds Illinois sellers.
The bulletin, Informational Bulletin FY 2027-04, "Hemp Product Changes, Effective November 12, 2026," says those products no longer meet the state's definition of hemp under Public Act 104-0463. They may be grown and sold to consumers in Illinois only under the Cannabis Regulation and Tax Act (CRTA). For a smoke shop, convenience store or online brand shipping into Illinois, the practical question is not what Congress does next; it is which of your SKUs sit above 0.4 mg per container on that date.
Under the bulletin, the line is total THC per container, and total THC includes THCA. Products above it become cannabis. Only licensed channels can touch them: the bulletin says only cultivators licensed by the Illinois Department of Agriculture may grow cannabis under the CRTA, and that only dispensaries licensed by the Illinois Department of Financial and Professional Regulation may sell products above 0.4 mg per container. A business that does not hold a CRTA license may not possess a failing hemp product with intent to sell it.
Products that stay below the line can be sold under the new Illinois Hemp Act as a "final consumer hemp cannabinoid product." As the bulletin describes that term, the product must contain no synthetic cannabinoids or synthetically manufactured naturally occurring cannabinoids; no more than 0.4 mg total THC per container (counting THCA and similar cannabinoids such as delta-8 THC, THC-P, HHC and THC-O); no alcohol, tobacco or nicotine; and only ingredients recognized as safe by the FDA. It cannot be intended for smoking or vaping, and it must arrive prepackaged rather than assembled at the point of sale.
The bulletin also covers what compliant products need: labels with the product name, net weight or volume, ingredients, cannabinoid identity and quantity, serving information, batch number, manufacturer contact details, an expiration date and a QR code to the certificate of analysis; lot-by-lot testing by a lab approved by the Department of Agriculture; and sealed, child-resistant packaging meeting federal Consumer Product Safety Commission standards. It does not state any tax rates, so this article does not either.
Congress moved most of the federal hemp redefinition to December 11, 2026 in Section 2019 of H.R. 6500, now Public Law 119-103, signed September 2. Only the piece covering cannabinoids not capable of being naturally produced by the cannabis plant stays at November 12 federally. Our explainer on the federal delay to December 11 walks through that split, and our guide to the 0.4 mg per-container cap covers how the federal number is counted.
Illinois did not wait. The bulletin says the state will enforce the Illinois Hemp Act starting November 12 regardless of the federal delay. A seller that plans to the federal December 11 date is a month late in Illinois. The reverse also holds: a product that is lawful hemp in Illinois after November 12 still has to clear the federal line on December 11.
| Item | Illinois (state) | Federal, first phase | Federal, balance |
|---|---|---|---|
| Date | November 12, 2026 | November 12, 2026 | December 11, 2026 |
| Authority | Public Act 104-0463; Illinois Hemp Act | Section 2019, P.L. 119-103 | Section 2019, P.L. 119-103 |
| What it reaches | Consumable and topical products above 0.4 mg total THC per container | Products with cannabinoids not capable of being naturally produced by the plant | The total-THC redefinition, the 0.4 mg cap and the synthesized-outside-the-plant exclusion |
| Result | Product becomes cannabis; CRTA channel only | Product falls outside the federal hemp definition | Product falls outside the federal hemp definition |
Three points are open. First, the parts of the bulletin we reviewed describe no sell-through or grace period for inventory already on shelves, so a retailer cannot assume one exists. Second, the bulletin states that it does not replace statutes, rules or court decisions, which means the statute and any later rulemaking control. Third, the line between "naturally derived" and synthesized matters for both governments, and the evidence standard for it is still developing; see our piece on synthesized versus naturally derived cannabinoids.
Illinois is narrowing its hemp market by statute, with a hard date. Ohio is narrowing a related market through a 0.4 mg beverage limit that is being fought in court; our coverage of Ohio's 0.4 mg beverage fight describes an injunction that reaches only ten companies, leaving a split market. Massachusetts voters, by contrast, will decide on November 3 whether to narrow the adult-use cannabis market by ballot; see our look at Massachusetts Question 8. For the wider map of state hemp deadlines, see state hemp deadlines, and for where THCA stands state by state, THCA legality by state.
Earlier Illinois coverage still applies: Illinois's 2026 cannabis omnibus law explains what the underlying act changed, and Illinois THC beverage tax covers the earlier beverage-tax proposal.
Federally, the first phase for synthesized cannabinoids starts November 12, 2026, and the rest of the redefinition on December 11, 2026. In Illinois, the state 0.4 mg line applies on November 12.
Yes. The federal definition applies in every state, and Illinois separately moves above-line products into its licensed cannabis channel.
According to the Department of Revenue, those products become cannabis and may be sold to consumers only under the CRTA, by dispensaries licensed by the Illinois Department of Financial and Professional Regulation. Talk to your counsel about your specific products.
The bulletin counts total THC per container, including THCA, along with similar cannabinoids such as delta-8 THC, THC-P, HHC and THC-O in its definition of a final consumer hemp cannabinoid product.
This is regulatory journalism, not legal advice — talk to your counsel.
